欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0751/001
药品名称Epirubicin Hydrochloride
活性成分
    • epirubicin hydrochloride 2.0 mg/ml
剂型Injection
上市许可持有人Accord Healthcare Ireland Ltd., Euro House, Euro Business Park, Little Island, Cork T45 K857, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 20075/0024-0030
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Epirubicin Accord
    • Latvia (LV)
    • Lithuania (LT)
      Epirubicin Accord 2mg/ml injekcinis/infuzinis tirpalas
    • Estonia (EE)
      EPIRUBICIN ACCORD
    • Hungary (HU)
      EPIRUBICIN ACCORD 2 mg/ml oldatos injekció vagy infúzió
    • Czechia (CZ)
    • Slovakia (SK)
    • Austria (AT)
      Epirubicin Accord 2 mg/ml Lösung zur Injektion oder Infusion
许可日期2009/01/13
最近更新日期2024/02/19
药物ATC编码
    • L01DB03 epirubicin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase